Saladax develops novel blood tests that increase the impact of personalized medicine by bringing che
Location: United States, Pennsylvania, Bethlehem
Phone: +1 610-419-6731
Total raised: $30.4M
Investors 4
| Date | Name | Website |
| - | Memorial C... | memorialca... |
| - | Columbia V... | colventure... |
| - | Excel Vent... | excelvm.co... |
| - | Life Scien... | lsgpa.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.03.2013 | - | $22.4M | - |
| 05.03.2010 | Series C | $8M | - |
Mentions in press and media 4
| Date | Title | Description |
| 26.06.2018 | Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents | BETHLEHEM, Pa.–(BUSINESS WIRE)–June 26, 2018– Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels for adherence and medication management, has signed a license agreement with Janssen Pharmaceutica, NV... |
| 08.11.2013 | Women investors can increase funding in Philadelphia: Gloria Rabinowitz | Only 1.5 percent of the country’s venture capital is invested in the Philadelphia region. But Gloria Rabinowitz isn’t worried. “It’s upside,” she said. “It’s all upside.” What Rabinowitz, a local angel investor and entrepreneur, means is: t... |
| 05.03.2013 | Saladax Biomedical Receives $22.4M Strategic Equity Investment | Saladax Biomedical, Inc., a Bethlehem, Pennsylvania-based company developing and commercializing novel diagnostic assays, received a $22.4m strategic equity investment. The backer was Shanghai Fosun Pharmaceutical Co., Ltd. (Fosun Pharma: 6... |
| 05.03.2010 | Saladax Biomedical Closes $8 Million Series C Financing | Saladax Biomedical, Inc., a Bethlehem, PA-based company which develops novel diagnostic tests for the practical delivery of personalized medicine, closed its $8.4m Series C financing led by Excel Venture Management of Boston. Participants i... |